Tobramycin Pregnancy and Breastfeeding Warnings
Tobramycin Pregnancy Warnings
Tobramycin has been assigned to pregnancy category D by the FDA. There are no controlled data in human pregnancies. Tobramycin crosses the placenta. While adverse fetal effects have not been noted after tobramycin use during pregnancy, there are reports of fetal eighth cranial nerve toxicity with permanent bilateral deafness after in utero exposure to other aminoglycosides. Tobramycin should only be given during pregnancy when benefit outweighs risk.
Tobramycin Breastfeeding Warnings
Parenteral: Tobramycin is excreted in human milk. Trace amounts have been measured in milk after intramuscular injection. Due to poor oral bioavailability, systemic toxicity in the nursing infant is unlikely; however, the possibility of bowel flora modification and interference with culture results should be considered. Inhalation: It is unknown whether nebulized tobramycin would reach sufficient serum concentrations to be excreted in human milk. Due to poor oral bioavailability, systemic toxicity in the nursing infant is unlikely; however, the manufacturer recommends that because of the potential for ototoxicity and nephrotoxicity in the nursing infant, a decision should be made whether to discontinue nursing or inhalation therapy.
- Tobramycin use while Breastfeeding (in more detail)
- tobramycin Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.